Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.

@article{Seeman1990ElevationOD,
  title={Elevation of dopamine D2 receptors in schizophrenia is underestimated by radioactive raclopride.},
  author={P. Seeman and H. Niznik and H. Guan},
  journal={Archives of general psychiatry},
  year={1990},
  volume={47 12},
  pages={
          1170-2
        }
}
  • P. Seeman, H. Niznik, H. Guan
  • Published 1990
  • Psychology, Medicine
  • Archives of general psychiatry
    • To the Editor.— In schizophrenia, the brain reveals elevated densities of dopamine D 2 receptors whether or not the patients have received neuroleptic medications. 1-3 In addition, the left putamen in schizophrenia shows D 2 to be elevated by 2.8 pmol/mL, significantly different from the right side, but nonsignificantly elevated by 3.2 pmol/mL compared with controls. 4 It has been puzzling that these unilateral elevations of 2.8 to 3.2 pmol/mL, seen with [ 11 C]raclopride, are less than the… CONTINUE READING
    View on PubMed
    doi.org
    60 Citations
    Highly Influential Citations
    2
    Background Citations
    12
    Results Citations
    3

    Topics from this paper

    Explore Further: Topics Discussed in This Paper

    60 Citations
    Citation Type

    Citation Type

    Increased baseline occupancy of D2 receptors by dopamine in schizophrenia.
    • 934
    • PDF
    Dopamine D4 receptors and effects of guanine nucleotides on [3H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression
    • 114
    Imaging D2 Receptor Occupancy by Endogenous Dopamine in Humans
    • 260
    • PDF
    Effect of amphetamine on extrastriatal D2 dopamine receptor binding in the primate brain: A PET study
    • 61
    Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography.
    • 178
    Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients
    • 486
    Savoxepine: striatal dopamine-D2 receptor occupancy in human volunteers measured using positron emission tomography (PET)
    • 5
    Dopamine D2 receptor density estimates in schizophrenia: A positron emission tomography study with11C-N-methylspiperone
    • 88
    The cloned dopamine D2 receptor reveals different densities for dopamine receptor antagonist ligands. Implications for human brain positron emission tomography.
    • 64
    Competition between 11C-raclopride and endogenous dopamine in Parkinson's disease
    • 16

    References

    SHOWING 1-10 OF 12 REFERENCES
    D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride.
    • 507
    Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum.
    • 78
    • PDF
    Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics.
    • 884
    Link between D1 and D2 dopamine receptors is reduced in schizophrenia and Huntington diseased brain.
    • 174
    • PDF
    Dopamine receptors and transporters in Parkinson's disease and schizophrenia
    • P. Seeman, H. Niznik
    • Medicine
    • FASEB journal : official publication of the Federation of American Societies for Experimental Biology
    • 1990
    • 273
    Organization of dopamine D1 and D2 receptors in human striatum: Receptor autoradiographic studies in Huntington's disease and schizophrenia
    • 175
    Human brain dopamine receptors in children and aging adults
    • 385
    Bimodal distribution of dopamine receptor densities in brains of schizophrenics.
    • 333
    Kinetic properties of the accumulation of 3H-raclopride in the mouse brain in vivo
    • 43
    Loss of striatal dopaminergic receptors after intrastriatal kainic acid injection.
    • 80